BIRC5 and neoplasm: The higher expression of Survivin‐∆EX3 compared to survivin‐2B in SCC samples may be linked to P53 mutation, which enhance Survivin‐∆EX3 expression and contribute to tumor progression (Mishra et al. 2015).